1. Home
  2. GKOS vs MRCY Comparison

GKOS vs MRCY Comparison

Compare GKOS & MRCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$116.08

Market Cap

5.4B

Sector

Health Care

ML Signal

HOLD

Logo Mercury Systems Inc

MRCY

Mercury Systems Inc

HOLD

Current Price

$69.78

Market Cap

4.5B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
GKOS
MRCY
Founded
1998
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.4B
4.5B
IPO Year
2015
1998

Fundamental Metrics

Financial Performance
Metric
GKOS
MRCY
Price
$116.08
$69.78
Analyst Decision
Strong Buy
Buy
Analyst Count
13
7
Target Price
$125.54
$76.43
AVG Volume (30 Days)
865.8K
662.9K
Earning Date
10-29-2025
02-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$469,820,000.00
$932,798,000.00
Revenue This Year
$31.15
$6.47
Revenue Next Year
$24.15
$8.65
P/E Ratio
N/A
N/A
Revenue Growth
30.38
8.63
52 Week Low
$73.16
$38.16
52 Week High
$163.71
$85.33

Technical Indicators

Market Signals
Indicator
GKOS
MRCY
Relative Strength Index (RSI) 76.42 44.91
Support Level $105.88 $68.81
Resistance Level $116.72 $77.56
Average True Range (ATR) 3.26 2.60
MACD 0.07 -0.05
Stochastic Oscillator 94.61 25.85

Price Performance

Historical Comparison
GKOS
MRCY

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About MRCY Mercury Systems Inc

Mercury Systems Inc is a commercial technology company serving the aerospace and defense industry. The company envisions, creates, and delivers secure open architecture solutions powering a broad range of mission-critical applications in challenging and demanding environments. Its Mercury Processing Platform spans the full breadth of signal processing from radio frequency front end to the human-machine interface to convert meaningful data, gathered in remote and hostile environments, into critical decisions. The company manufactures components, products, modules, and subsystems and sells to defense prime contractors, the U.S. government, original equipment manufacturers, and commercial aerospace companies. Geographically, it derives maximum revenue from the United States.

Share on Social Networks: